ENvue Medical (FEED) Shareholder's Equity Growth (1y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | ENvue Medical | 2.97 Mn | 709,615.89 | -55,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -10.26% |
| Dec 31, 2025 | 5,242.42% |
| Sep 30, 2025 | 2,168.38% |
| Jun 30, 2025 | 1,324.74% |
| Mar 31, 2025 | 918.12% |
| Dec 31, 2024 | -84.28% |
| Sep 30, 2024 | -60.09% |
| Jun 30, 2024 | 143.86% |
| Mar 31, 2024 | 59.06% |
| Dec 31, 2023 | 23.38% |
| Sep 30, 2023 | 48.70% |
| Jun 30, 2023 | -71.82% |
| Mar 31, 2023 | -58.13% |
| Dec 31, 2022 | -48.79% |
| Sep 30, 2022 | -63.79% |
| Jun 30, 2022 | -0.72% |
| Mar 31, 2022 | 21.03% |
| Dec 31, 2021 | 163.70% |
| Sep 30, 2021 | 166.64% |
| Jun 30, 2021 | 631.12% |
| Mar 31, 2021 | 772.89% |
| Dec 31, 2020 | 77.73% |
| Sep 30, 2020 | 46.50% |
| Jun 30, 2020 | -140.52% |
| Mar 31, 2020 | 206.18% |
| Dec 31, 2019 | 190.93% |
| Sep 30, 2019 | 60.89% |
| Jun 30, 2019 | -12.84% |
| Mar 31, 2019 | -115.88% |
| Dec 31, 2018 | -87.26% |
| Sep 30, 2018 | 132.32% |
| Jun 30, 2018 | 172.76% |
| Mar 31, 2018 | 205.39% |
| Dec 31, 2017 | 245.42% |
| Sep 30, 2017 | -167.56% |
| Jun 30, 2017 | -163.02% |
| Mar 31, 2017 | -362.54% |
| Dec 31, 2016 | -1,095.69% |
| Sep 30, 2016 | -417.43% |
| Jun 30, 2016 | -178.80% |
| Mar 31, 2016 | -364.63% |
| Dec 31, 2015 | 96.28% |
| Sep 30, 2015 | 110.27% |
| Jun 30, 2015 | 135.41% |
| Mar 31, 2015 | 106.11% |